| Product Code: ETC269541 | Publication Date: Aug 2022 | Updated Date: Jul 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The China Radiotherapy Market was estimated at USD 208 Million in 2025 and is projected to reach USD 240 Million by 2032, growing at a CAGR of 2.1% from 2026 to 2032. This growth trajectory is largely driven by the rising incidence of cancer, a trend amplified by an aging population and lifestyle factors. Additionally, the increasing implementation of advanced radiotherapy technologies, coupled with supportive government policies, is enhancing treatment accessibility and effectiveness.
This graph highlights how the China Radiotherapy Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -3.5% | decreased patient treatment availability |
| 2022 | 6.1% | increased healthcare funding allocations |
| 2023 | -1.7% | lower downstream application uptake |
| 2024 | 4.3% | growing patient population demand |
| 2025 | 3.4% | expansion of treatment facilities |
| 2026 | 4.4% | rising prevalence of cancer cases |
| 2027 | 2.6% | enhanced research investment commitments |
| 2028 | 2.8% | broadened access to care options |
| 2029 | 2.5% | strengthened partnerships with hospitals |
| 2030 | 2.9% | growing awareness of preventive care |
| 2031 | 2.7% | improved reimbursement policies enacted |
| 2032 | 2.8% | advancements in treatment methodologies |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
The Chinese radiotherapy landscape is transforming rapidly, fueled by a significant rise in cancer cases and technological advancements in treatment methods. This shift emphasizes the importance of radiotherapy as a cornerstone in oncology, helping to manage the growing burden of cancer across diverse demographics.
As hospitals upgrade their facilities and invest in state-of-the-art equipment, the market is seeing a surge in demand for innovative techniques such as IMRT and proton therapy. However, the availability of these advanced options remains inconsistent, particularly in rural areas, revealing disparities in healthcare access that challenge overall market growth.
One of the most pressing challenges in the China Radiotherapy Market is the uneven distribution of radiotherapy facilities and services, which often leaves rural communities underserved. This discrepancy in access to advanced treatment options limits the effectiveness of technological advancements. Moreover, the high costs associated with radiotherapy equipment and its maintenance create financial barriers for many healthcare institutions, hindering their ability to invest in necessary upgrades. Compounding these issues is the critical shortage of trained radiotherapy professionals, which undermines the potential for maximizing the use of existing technology and equipment.
Emerging trends in the China Radiotherapy Market reflect a growing preference for minimally invasive treatment options. Techniques such as SBRT are becoming increasingly popular due to their ability to target tumors precisely while sparing surrounding healthy tissue. Additionally, the integration of artificial intelligence in radiotherapy planning and patient management is gaining traction, promising enhanced treatment personalization and efficiency.
Significant growth opportunities lie in expanding radiotherapy services to underserved regions, particularly rural areas where access is limited. Investment in training programs for healthcare professionals can alleviate the skill gap and enhance service delivery. Furthermore, as demand for advanced technologies continues to rise, there is potential for partnerships between private companies and public institutions to foster innovation and improve overall treatment accessibility.
The Chinese government has enacted various policies to enhance cancer treatment accessibility and quality. Investments aimed at expanding healthcare infrastructure focus on building and upgrading radiotherapy facilities, especially in rural and underserved areas. Additionally, subsidies and funding programs encourage hospitals to adopt innovative radiotherapy techniques. The promotion of public-private partnerships further supports the efficient dissemination of advanced cancer treatment options across the nation.
Looking ahead to 2026-2032, the China Radiotherapy Market is poised for steady growth driven by ongoing advancements in treatment technologies and supportive government policies. The increasing incidence of cancer and a more comprehensive approach to healthcare are expected to fuel demand for radiotherapy services. With a focus on bridging the access gap and addressing workforce challenges, the market is likely to evolve, ensuring that more patients receive timely and effective cancer treatment.
Recent developments in the China Radiotherapy Market indicate a strong momentum towards enhancing treatment capabilities. There has been a notable increase in collaborations aimed at upgrading hospital infrastructure and expanding access to advanced radiotherapy technologies. These initiatives reflect a concerted effort to address existing disparities in cancer care, ensuring that more patients benefit from state-of-the-art treatment options.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Radiotherapy Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Radiotherapy Market Revenues & Volume, 2022 & 2032F |
3.3 China Radiotherapy Market - Industry Life Cycle |
3.4 China Radiotherapy Market - Porter's Five Forces |
3.5 China Radiotherapy Market Revenues & Volume Share, By Product, 2022 & 2032F |
3.6 China Radiotherapy Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.7 China Radiotherapy Market Revenues & Volume Share, By Procedure, 2022 & 2032F |
3.8 China Radiotherapy Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 China Radiotherapy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer cases in China |
4.2.2 Technological advancements in radiotherapy equipment |
4.2.3 Growing investments in healthcare infrastructure in China |
4.3 Market Restraints |
4.3.1 High cost associated with radiotherapy treatment |
4.3.2 Limited access to advanced radiotherapy facilities in rural areas of China |
5 China Radiotherapy Market Trends |
6 China Radiotherapy Market, By Types |
6.1 China Radiotherapy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 China Radiotherapy Market Revenues & Volume, By Product, 2022-2032F |
6.1.3 China Radiotherapy Market Revenues & Volume, By External Beam Radiotherapy, 2022-2032F |
6.1.4 China Radiotherapy Market Revenues & Volume, By Electron-emitting High-energy Linear Accelerators, 2022-2032F |
6.1.5 China Radiotherapy Market Revenues & Volume, By Conventional Linear Accelerators, 2022-2032F |
6.1.6 China Radiotherapy Market Revenues & Volume, By Stereotactic Advanced Electron/Cobalt-60 Linear Accelerators, 2022-2032F |
6.1.7 China Radiotherapy Market Revenues & Volume, By Conventional Cobalt-60 Teletherapy Units, 2022-2032F |
6.1.8 China Radiotherapy Market Revenues & Volume, By Particle Therapy Systems, 2022-2032F |
6.1.9 China Radiotherapy Market Revenues & Volume, By Systemic Radiotherapy, 2022-2032F |
6.1.10 China Radiotherapy Market Revenues & Volume, By Systemic Radiotherapy, 2022-2032F |
6.2 China Radiotherapy Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Radiotherapy Market Revenues & Volume, By External Beam Radiotherapy, 2022-2032F |
6.2.3 China Radiotherapy Market Revenues & Volume, By Internal Beam Radiotherapy/Brachytherapy, 2022-2032F |
6.3 China Radiotherapy Market, By Procedure |
6.3.1 Overview and Analysis |
6.3.2 China Radiotherapy Market Revenues & Volume, By External Beam Radiotherapy, 2022-2032F |
6.3.3 China Radiotherapy Market Revenues & Volume, By Internal Beam Radiotherapy/Brachytherapy, 2022-2032F |
6.3.4 China Radiotherapy Market Revenues & Volume, By Systemic Radiotherapy, 2022-2032F |
6.3.5 China Radiotherapy Market Revenues & Volume, By Intravenous Radiotherapy, 2022-2032F |
6.3.6 China Radiotherapy Market Revenues & Volume, By Oral Radiotherapy, 2022-2032F |
6.3.7 China Radiotherapy Market Revenues & Volume, By Instillation Radiotherapy, 2022-2032F |
6.4 China Radiotherapy Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 China Radiotherapy Market Revenues & Volume, By Hospitals, 2022-2032F |
6.4.3 China Radiotherapy Market Revenues & Volume, By Independent Radiotherapy Centers, 2022-2032F |
7 China Radiotherapy Market Import-Export Trade Statistics |
7.1 China Radiotherapy Market Export to Major Countries |
7.2 China Radiotherapy Market Imports from Major Countries |
8 China Radiotherapy Market Key Performance Indicators |
8.1 Average waiting time for radiotherapy treatment in China |
8.2 Adoption rate of advanced radiotherapy techniques in Chinese hospitals |
8.3 Percentage of hospitals in China offering radiotherapy services with state-of-the-art equipment |
9 China Radiotherapy Market - Opportunity Assessment |
9.1 China Radiotherapy Market Opportunity Assessment, By Product, 2022 & 2032F |
9.2 China Radiotherapy Market Opportunity Assessment, By Application, 2022 & 2032F |
9.3 China Radiotherapy Market Opportunity Assessment, By Procedure, 2022 & 2032F |
9.4 China Radiotherapy Market Opportunity Assessment, By End User, 2022 & 2032F |
10 China Radiotherapy Market - Competitive Landscape |
10.1 China Radiotherapy Market Revenue Share, By Companies, 2025 |
10.2 China Radiotherapy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here